{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:30:30Z","timestamp":1790857830153,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/aps.2016.149","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T05:00:55Z","timestamp":1483938055000},"page":"312-316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Brain cannabinoid receptor 2: expression, function and modulation"],"prefix":"10.1038","volume":"38","author":[{"given":"De-jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen-fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"BFaps2016149_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M . Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61\u20135.","journal-title":"Nature"},{"key":"BFaps2016149_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Gali\u00e8gue","year":"1995","unstructured":"Gali\u00e8gue S, Mary S, Marchand J, Dussossoy D, Carri\u00e8re D, Carayon P, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54\u201361.","journal-title":"Eur J Biochem"},{"key":"BFaps2016149_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1006\/taap.1996.8034","volume":"142","author":"AR Schatz","year":"1997","unstructured":"Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE . Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 1997; 142: 278\u201387.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFaps2016149_CR4","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0022-3565(24)38313-2","volume":"289","author":"KL McCoy","year":"1999","unstructured":"McCoy KL, Matveyeva M, Carlisle SJ, Cabral GA . Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J Pharmacol Exp Ther 1999; 289: 1620\u20135.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps2016149_CR5","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1523\/JNEUROSCI.5404-03.2004","volume":"24","author":"G Burdyga","year":"2004","unstructured":"Burdyga G, Lal S, Varro A, Dimaline R, Thompson DG, Dockray GJ . Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J Neurosci 2004; 24: 2708\u201315.","journal-title":"J Neurosci"},{"key":"BFaps2016149_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","volume":"396","author":"NE Buckley","year":"2000","unstructured":"Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur J Pharmacol 2000; 396: 141\u20139.","journal-title":"Eur J Pharmacol"},{"key":"BFaps2016149_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/sj.bjp.0707527","volume":"153","author":"NE Buckley","year":"2008","unstructured":"Buckley NE . The peripheral cannabinoid receptor knockout mice: an update. Br J Pharmacol 2008; 153: 309\u201318.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1124\/pr.110.003491","volume":"63","author":"LK Miller","year":"2011","unstructured":"Miller LK, Devi LA . The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev 2011; 63: 461\u201370.","journal-title":"Pharmacol Rev"},{"key":"BFaps2016149_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1196\/annals.1432.036","volume":"1139","author":"ES Onaivi","year":"2008","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Meozzi PA, Myers L, et al. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann N Y Acad Sci 2008; 1139: 434\u201349.","journal-title":"Ann N Y Acad Sci"},{"key":"BFaps2016149_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/0269881111400652","volume":"26","author":"ES Onaivi","year":"2012","unstructured":"Onaivi ES, Ishiguro H, Gu S, Liu QR . CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity. J Psychopharmacol (Oxford) 2012; 26: 92\u2013103.","journal-title":"J Psychopharmacol (Oxford)"},{"key":"BFaps2016149_CR11","doi-asserted-by":"publisher","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","volume":"111","author":"HY Zhang","year":"2014","unstructured":"Zhang HY, Gao M, Liu QR, Bi GH, Li X, Yang HJ, et al. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proc Natl Acad Sci U S A 2014; 111: E5007\u201315.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps2016149_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","volume":"50","author":"P Pacher","year":"2011","unstructured":"Pacher P, Mechoulam R . Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog Lipid Res 2011; 50: 193\u2013211.","journal-title":"Prog Lipid Res"},{"key":"BFaps2016149_CR13","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/j.mce.2008.01.001","volume":"286","author":"J Fern\u00e1ndez-Ruiz","year":"2008","unstructured":"Fern\u00e1ndez-Ruiz J, Pazos MR, Garc\u00eda-Arencibia M, Sagredo O, Ramos JA . Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 2008; 286: S91\u20136.","journal-title":"Mol Cell Endocrinol"},{"key":"BFaps2016149_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00210-013-0930-8","volume":"387","author":"B C\u00e9cyre","year":"2014","unstructured":"C\u00e9cyre B, Thomas S, Ptito M, Casanova C, Bouchard JF . Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina. Naunyn Schmiedebergs Arch Pharmacol 2014; 387: 175\u201384.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFaps2016149_CR15","doi-asserted-by":"publisher","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","volume":"287","author":"L Call\u00e9n","year":"2012","unstructured":"Call\u00e9n L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cort\u00e9s A, Mallol J, et al. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. J Biol Chem 2012; 287: 20851\u201365.","journal-title":"J Biol Chem"},{"key":"BFaps2016149_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1113\/jphysiol.2014.286633","volume":"593","author":"J Kim","year":"2015","unstructured":"Kim J, Li Y . Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission. J Physiol (Lond) 2015; 593: 871\u201386.","journal-title":"J Physiol (Lond)"},{"key":"BFaps2016149_CR17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","volume":"90","author":"AV Stempel","year":"2016","unstructured":"Stempel AV, Stumpf A, Zhang HY, \u00d6zdo\u011fan T, Pannasch U, Theis AK, et al. Cannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampus. Neuron 2016; 90: 795\u2013809.","journal-title":"Neuron"},{"key":"BFaps2016149_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","volume":"91","author":"DJ Foster","year":"2016","unstructured":"Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, et al. Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release. Neuron 2016; 91: 1244\u201352.","journal-title":"Neuron"},{"key":"BFaps2016149_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881110367732","volume":"25","author":"JL Lanciego","year":"2011","unstructured":"Lanciego JL, Barroso-Chinea P, Rico AJ, Conte-Perales L, Call\u00e9n L, Roda E, et al. Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J Psychopharmacol (Oxford) 2011; 25: 97\u2013104.","journal-title":"J Psychopharmacol (Oxford)"},{"key":"BFaps2016149_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S0952523800171093","volume":"17","author":"Q Lu","year":"2000","unstructured":"Lu Q, Straiker A, Lu Q, Maguire G . Expression of CB2 cannabinoid receptor mRNA in adult rat retina. Vis Neurosci 2000; 17: 91\u20135.","journal-title":"Vis Neurosci"},{"key":"BFaps2016149_CR21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","volume":"8","author":"QR Liu","year":"2009","unstructured":"Liu QR, Pan CH, Hishimoto A, Li CY, Xi ZX, Llorente-Berzal A, et al. Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav 2009; 8: 519\u201330.","journal-title":"Genes Brain Behav"},{"key":"BFaps2016149_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/j.1476-5381.2011.01625.x","volume":"165","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2012","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Garc\u00eda-Bueno B, Zoppi S, Leza JC, Manzanares J . Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors. Br J Pharmacol 2012; 165: 951\u201364.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1476-5381.2011.01542.x","volume":"165","author":"F Navarrete","year":"2012","unstructured":"Navarrete F, P\u00e9rez-Ortiz JM, Manzanares J . Cannabinoid CB2 receptor-mediated regulation of impulsive-like behaviour in DBA\/2 mice. Br J Pharmacol 2012; 165: 260\u201373.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.neuroscience.2015.10.041","volume":"311","author":"Y Li","year":"2015","unstructured":"Li Y, Kim J . Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus. Neuroscience 2015; 311: 253\u201367.","journal-title":"Neuroscience"},{"key":"BFaps2016149_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Van Sickle","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329\u201332.","journal-title":"Science"},{"key":"BFaps2016149_CR26","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","volume":"29","author":"MT Viscomi","year":"2009","unstructured":"Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, et al. Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway. J Neurosci 2009; 29: 4564\u201370.","journal-title":"J Neurosci"},{"key":"BFaps2016149_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neulet.2005.11.038","volume":"396","author":"JC Ashton","year":"2006","unstructured":"Ashton JC, Friberg D, Darlington CL, Smith PF . Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 2006; 396: 113\u20136.","journal-title":"Neurosci Lett"},{"key":"BFaps2016149_CR28","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/00016480701796944","volume":"128","author":"JH Baek","year":"2008","unstructured":"Baek JH, Zheng Y, Darlington CL, Smith PF . Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei. Acta Otolaryngol 2008; 128: 961\u20137.","journal-title":"Acta Otolaryngol"},{"key":"BFaps2016149_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/syn.20569","volume":"62","author":"A Brusco","year":"2008","unstructured":"Brusco A, Tagliaferro P, Saez T, Onaivi ES . Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 2008; 62: 944\u20139.","journal-title":"Synapse"},{"key":"BFaps2016149_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"JP Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research 2006; 1071: 10\u201323.","journal-title":"Brain Research"},{"key":"BFaps2016149_CR31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.20983","volume":"58","author":"N Stella","year":"2010","unstructured":"Stella N . Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 2010; 58: 1017\u201330.","journal-title":"Glia"},{"key":"BFaps2016149_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1189\/jlb.0405216","volume":"78","author":"GA Cabral","year":"2005","unstructured":"Cabral GA, Marciano-Cabral F . Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol 2005; 78: 1192\u20137.","journal-title":"J Leukoc Biol"},{"key":"BFaps2016149_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","volume":"153","author":"GA Cabral","year":"2008","unstructured":"Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F . CB2 receptors in the brain: role in central immune function. Br J Pharmacol 2008; 153: 240\u201351.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR34","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.lfs.2004.03.026","volume":"75","author":"MR Pazos","year":"2004","unstructured":"Pazos MR, N\u00fa\u00f1ez E, Benito C, Tol\u00f3n RM, Romero J . Role of the endocannabinoid system in Alzheimer's disease: new perspectives. Life Sci 2004; 75: 1907\u201315.","journal-title":"Life Sci"},{"key":"BFaps2016149_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/187152410790780145","volume":"10","author":"JR Rivers","year":"2010","unstructured":"Rivers JR, Ashton JC . The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. Cent Nerv Syst Agents Med Chem 2010; 10: 47\u201364.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"BFaps2016149_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2174\/138955711795906905","volume":"11","author":"JP Little","year":"2011","unstructured":"Little JP, Villanueva EB, Klegeris A . Therapeutic potential of cannabinoids in the treatment of neuroinflammation associated with parkinsons disease. Mini Rev Med Chem 2011; 11: 582\u201390.","journal-title":"Mini Rev Med Chem"},{"key":"BFaps2016149_CR37","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","volume":"15","author":"B Szabo","year":"2002","unstructured":"Szabo B, Siemes S, Wallmichrath I . Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 2002; 15: 2057\u201361.","journal-title":"Eur J Neurosci"},{"key":"BFaps2016149_CR38","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.biopsych.2012.10.025","volume":"73","author":"S Dubreucq","year":"2013","unstructured":"Dubreucq S, Durand A, Matias I, B\u00e9nard G, Richard E, Soria-Gomez E, et al. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry 2013; 73: 895\u2013903.","journal-title":"Biol Psychiatry"},{"key":"BFaps2016149_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00424-015-1782-5","volume":"468","author":"\u00d6 Albayram","year":"2016","unstructured":"Albayram \u00d6, Passlick S, Bilkei-Gorzo A, Zimmer A, Steinh\u00e4user C . Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons. Pflugers Arch 2016; 468: 727\u201337.","journal-title":"Pflugers Arch"},{"key":"BFaps2016149_CR40","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1073\/pnas.1118167109","volume":"109","author":"FS den Boon","year":"2012","unstructured":"den Boon FS, Chameau P, Schaafsma-Zhao Q, van Aken W, Bari M, Oddi S, et al. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc Natl Acad Sci U S A 2012; 109: 3534\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps2016149_CR41","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.2174\/13816128113199990433","volume":"20","author":"S Vlachou","year":"2014","unstructured":"Vlachou S, Panagis G . Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals. Curr Pharm Des 2014; 20: 2072\u201388.","journal-title":"Curr Pharm Des"},{"key":"BFaps2016149_CR42","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1007\/s00125-010-1894-6","volume":"53","author":"J Agudo","year":"2010","unstructured":"Agudo J, Martin M, Roca C, Molas M, Bura AS, Zimmer A, et al. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age. Diabetologia 2010; 53: 2629\u201340.","journal-title":"Diabetologia"},{"key":"BFaps2016149_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neulet.2010.12.031","volume":"490","author":"B Ignatowska-Jankowska","year":"2011","unstructured":"Ignatowska-Jankowska B, Jankowski MM, Swiergiel AH . Cannabidiol decreases body weight gain in rats: involvement of CB2 receptors. Neurosci Lett 2011; 490: 82\u20134.","journal-title":"Neurosci Lett"},{"key":"BFaps2016149_CR44","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00359-011-0676-z","volume":"197","author":"L Emadi","year":"2011","unstructured":"Emadi L, Jonaidi H, Hosseini Amir Abad E . The role of central CB2 cannabinoid receptors on food intake in neonatal chicks. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2011; 197: 1143\u20137.","journal-title":"J Comp Physiol A Neuroethol Sens Neural Behav Physiol"},{"key":"BFaps2016149_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.joen.2011.09.015","volume":"38","author":"NM Flake","year":"2012","unstructured":"Flake NM, Zweifel LS . Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2. J Endod 2012; 38: 86\u201390.","journal-title":"J Endod"},{"key":"BFaps2016149_CR46","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","volume":"160","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2010","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, P\u00e9rez-Ortiz JM, Guti\u00e9rrez-Ad\u00e1n A, Manzanares J . Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors. Br J Pharmacol 2010; 160: 1773\u201384.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/0269881110379507","volume":"25","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2011","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Manzanares J . Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. J Psychopharmacol (Oxford) 2011; 25: 111\u201320.","journal-title":"J Psychopharmacol (Oxford)"},{"key":"BFaps2016149_CR48","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/npp.2011.34","volume":"36","author":"A Ortega-Alvaro","year":"2011","unstructured":"Ortega-Alvaro A, Aracil-Fern\u00e1ndez A, Garc\u00eda-Guti\u00e9rrez MS, Navarrete F, Manzanares J . Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 2011; 36: 1489\u2013504.","journal-title":"Neuropsychopharmacology"},{"key":"BFaps2016149_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/nn.2874","volume":"14","author":"ZX Xi","year":"2011","unstructured":"Xi ZX, Peng XQ, Li X, Song R, Zhang HY, Liu QR, et al. Brain cannabinoid CB2 receptors modulate cocaine's actions in mice. Nat Neurosci 2011 14: 1160\u20136.","journal-title":"Nat Neurosci"},{"key":"BFaps2016149_CR50","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/npp.2013.157","volume":"38","author":"F Navarrete","year":"2013","unstructured":"Navarrete F, Rodr\u00edguez-Arias M, Mart\u00edn-Garc\u00eda E, Navarro D, Garc\u00eda-Guti\u00e9rrez MS, Aguilar MA, et al. Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine. Neuropsychopharmacology 2013; 38: 2515\u201324.","journal-title":"Neuropsychopharmacology"},{"key":"BFaps2016149_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/adb.12076","volume":"20","author":"A Ortega-\u00c1lvaro","year":"2015","unstructured":"Ortega-\u00c1lvaro A, Ternianov A, Aracil-Fern\u00e1ndez A, Navarrete F, Garc\u00eda-Guti\u00e9rrez MS, Manzanares J . Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol. Addict Biol 2015; 20: 43\u201355.","journal-title":"Addict Biol"},{"key":"BFaps2016149_CR52","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1369\/0022155413491269","volume":"61","author":"IH Sv\u00edzensk\u00e1","year":"2013","unstructured":"Sv\u00edzensk\u00e1 IH, Br\u00e1zda V, Klus\u00e1kov\u00e1 I, Dubov\u00fd P . Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model. J Histochem Cytochem 2013; 61: 529\u201347.","journal-title":"J Histochem Cytochem"},{"key":"BFaps2016149_CR53","doi-asserted-by":"publisher","first-page":"e0132487","DOI":"10.1371\/journal.pone.0132487","volume":"10","author":"SJ Yu","year":"2015","unstructured":"Yu SJ, Reiner D, Shen H, Wu KJ, Liu QR, Wang Y . Time-dependent protection of CB2 receptor agonist in stroke. PLoS One 2015; 10: e0132487.","journal-title":"PLoS One"},{"key":"BFaps2016149_CR54","doi-asserted-by":"publisher","first-page":"e0128782","DOI":"10.1371\/journal.pone.0128782","volume":"10","author":"AB Lopez-Rodriguez","year":"2015","unstructured":"Lopez-Rodriguez AB, Acaz-Fonseca E, Viveros MP, Garcia-Segura LM . Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit. PLoS One 2015; 10: e0128782.","journal-title":"PLoS One"},{"key":"BFaps2016149_CR55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.expneurol.2016.06.014","volume":"283","author":"RM Concannon","year":"2016","unstructured":"Concannon RM, Okine BN, Finn DP, Dowd E . Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease. Exp Neurol 2016; 283: 204\u201312.","journal-title":"Exp Neurol"},{"key":"BFaps2016149_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnins.2016.00243","volume":"10","author":"E Aso","year":"2016","unstructured":"Aso E, Ferrer I . CB2 cannabinoid receptor as potential target against Alzheimer's disease. Front Neurosci 2016; 10: 243.","journal-title":"Front Neurosci"},{"key":"BFaps2016149_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.expneurol.2015.04.007","volume":"269","author":"RM Concannon","year":"2015","unstructured":"Concannon RM, Okine BN, Finn DP, Dowd E . Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease. Exp Neurol 2015; 269: 133\u201341.","journal-title":"Exp Neurol"},{"key":"BFaps2016149_CR58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.drugalcdep.2013.08.023","volume":"133","author":"M Agudelo","year":"2013","unstructured":"Agudelo M, Yndart A, Morrison M, Figueroa G, Mu\u00f1oz K, Samikkannu T, et al. Differential expression and functional role of cannabinoid genes in alcohol users. Drug Alcohol Depend 2013; 133: 789\u201393.","journal-title":"Drug Alcohol Depend"},{"key":"BFaps2016149_CR59","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1017\/S1461145712001186","volume":"16","author":"P Rivera","year":"2013","unstructured":"Rivera P, Migu\u00e9ns M, Coria SM, Rubio L, Higuera-Matas A, Berm\u00fadez-Silva FJ, et al. Cocaine self-administration differentially modulates the expression of endogenous cannabinoid system-related proteins in the hippocampus of Lewis vs Fischer 344 rats. Int J Neuropsychopharmacol 2013; 16: 1277\u201393.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFaps2016149_CR60","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","volume":"367","author":"RG Pertwee","year":"2012","unstructured":"Pertwee RG . Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci 2012; 367: 3353\u201363.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFaps2016149_CR61","doi-asserted-by":"publisher","first-page":"8224","DOI":"10.1021\/jm4005626","volume":"56","author":"S Han","year":"2013","unstructured":"Han S, Thatte J, Buzard DJ, Jones RM . Therapeutic utility of cannabinoid receptor type 2 (CB2) selective agonists. J Med Chem 2013; 56: 8224\u201356.","journal-title":"J Med Chem"},{"key":"BFaps2016149_CR62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"RG Pertwee","year":"2001","unstructured":"Pertwee RG . Cannabinoid receptors and pain. Prog Neurobiol 2001; 63: 569\u2013611.","journal-title":"Prog Neurobiol"},{"key":"BFaps2016149_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S1471-4892(02)00004-8","volume":"3","author":"T Malan Jr","year":"2003","unstructured":"Malan T. Jr, Ibrahim MM, Lai J, Vanderah TW, Makriyannis A, Porreca F . CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr Opin Pharmacol 2003; 3: 62\u20137.","journal-title":"Curr Opin Pharmacol"},{"key":"BFaps2016149_CR64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12035-007-8007-7","volume":"36","author":"MD Jhaveri","year":"2007","unstructured":"Jhaveri MD, Sagar DR, Elmes SJ, Kendall DA, Chapman V . Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain. Mol Neurobiol 2007; 36: 26\u201335.","journal-title":"Mol Neurobiol"},{"key":"BFaps2016149_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/138955709787001785","volume":"9","author":"M Beltramo","year":"2009","unstructured":"Beltramo M . Cannabinoid type 2 receptor as a target for chronic-pain. Mini Rev Med Chem 2009; 9: 11\u201325.","journal-title":"Mini Rev Med Chem"},{"key":"BFaps2016149_CR66","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11481-013-9445-9","volume":"8","author":"S Rom","year":"2013","unstructured":"Rom S, Persidsky Y . Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. J Neuroimmune Pharmacol 2013; 8: 608\u201320.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFaps2016149_CR67","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ajpath.2012.11.024","volume":"182","author":"IY Choi","year":"2013","unstructured":"Choi IY, Ju C, Anthony Jalin AM, Lee DI, Prather PL, Kim WK . Activation of cannabinoid CB2 receptor-mediated AMPK\/CREB pathway reduces cerebral ischemic injury. Am J Pathol 2013; 182: 928\u201339.","journal-title":"Am J Pathol"},{"key":"BFaps2016149_CR68","doi-asserted-by":"publisher","first-page":"824093","DOI":"10.1155\/2012\/824093","volume":"2012","author":"LS Capettini","year":"2012","unstructured":"Capettini LS, Savergnini SQ, da Silva RF, Stergiopulos N, Santos RA, Mach F, et al. Update on the role of cannabinoid receptors after ischemic stroke. Mediators Inflamm 2012; 2012: 824093.","journal-title":"Mediators Inflamm"},{"key":"BFaps2016149_CR69","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fphar.2014.00037","volume":"5","author":"E Aso","year":"2014","unstructured":"Aso E, Ferrer I . Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. Front Pharmacol 2014; 5: 37.","journal-title":"Front Pharmacol"},{"key":"BFaps2016149_CR70","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","volume":"163","author":"J Fern\u00e1ndez-Ruiz","year":"2011","unstructured":"Fern\u00e1ndez-Ruiz J, Moreno-Martet M, Rodr\u00edguez-Cueto C, Palomo-Garo C, G\u00f3mez-Ca\u00f1as M, Valdeolivas S, et al. Prospects for cannabinoid therapies in basal ganglia disorders. Br J Pharmacol 2011; 163: 1365\u201378.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR71","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","volume":"29","author":"DA Price","year":"2009","unstructured":"Price DA, Martinez AA, Seillier A, Koek W, Acosta Y, Fernandez E, et al. WIN55, 212\u20132, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci 2009; 29: 2177\u201386.","journal-title":"Eur J Neurosci"},{"key":"BFaps2016149_CR72","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","volume":"163","author":"C Garc\u00eda","year":"2011","unstructured":"Garc\u00eda C, Palomo-Garo C, Garc\u00eda-Arencibia M, Ramos J, Pertwee R, Fern\u00e1ndez-Ruiz J . Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson's disease. Br J Pharmacol 2011; 163: 1495\u2013506.","journal-title":"Br J Pharmacol"},{"key":"BFaps2016149_CR73","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","volume":"64","author":"Y G\u00f3mez-G\u00e1lvez","year":"2016","unstructured":"G\u00f3mez-G\u00e1lvez Y, Palomo-Garo C, Fern\u00e1ndez-Ruiz J, Garc\u00eda C . Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 2016; 64: 200\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFaps2016149_CR74","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/brain\/awp239","volume":"132","author":"J Palazuelos","year":"2009","unstructured":"Palazuelos J, Aguado T, Pazos MR, Julien B, Carrasco C, Resel E, et al. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 2009; 132: 3152\u201364.","journal-title":"Brain"},{"key":"BFaps2016149_CR75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/glia.20838","volume":"57","author":"O Sagredo","year":"2009","unstructured":"Sagredo O, Gonz\u00e1lez S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, et al. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia 2009; 57: 1154\u201367.","journal-title":"Glia"},{"key":"BFaps2016149_CR76","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","volume":"156","author":"RG Pertwee","year":"2009","unstructured":"Pertwee RG . Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 2009; 156: 397\u2013411.","journal-title":"Br J Pharmacol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2016149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2016149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2016149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T23:47:13Z","timestamp":1749858433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2016149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFaps2016149"],"URL":"https:\/\/doi.org\/10.1038\/aps.2016.149","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"assertion":[{"value":"11 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}